Navegar por autor "del Campo Pérez, Victor Miguel"

Mostrando ítems 1-9 de 9

Alerta sanitaria por ébola: Actuaciones realizadas en un hospital de referencia

2015- del Campo Pérez, Victor Miguel; Lameiro Vilariño, Maria del Carmen; Besteiro Eguia, Ana; Cuevas Raposo, Alejandro; Perez Alvarellos, Luis Alberto [et al.]
Analysis of disease activity and response to treatment in a large Spanish cohort of patients with systemic lupus erythematosus

2015- Freire Gonzalez, Mercedes; del Campo Pérez, Victor Miguel; Pego Reigosa, José María
Can we validate a clinical score to predict the risk of severe infection in patients with systemic lupus erythematosus? A longitudinal retrospective study in a British Cohort

2019- Tejera Segura, B.; Rua-Figueroa, I.; Pego Reigosa, José María; del Campo Pérez, Victor Miguel; Wincup, C.; [et al.]
Comparative analysis of eleven SARS-CoV-2 immunoassays and neutralisation data: time to enhance standardisation and correlation of protection.

2024- Cabrera Alvargonzález, Jorge Julio; Daviña Núñez, Carlos; Rey Cao, Sonia; Rodriguez Calviño, Leticia; Silva Bea, Sergio; [et al.]
Creutzfeldt-Jakob disease cluster in the health area of Meixoeiro Hospital

2013- del Campo Pérez, Victor Miguel; Maciñeiras Montero, José Luis; Escriche Jaime, Dolores; Moreno Carretero, María José; Corredera García, Enrique; [et al.]
Identification of candidate host serum and saliva biomarkers for a better diagnosis of active and latent tuberculosis infection

2020- Estevez, O.; Anibarro, L.; Garet, E.; Pallares, A.; Pena, A.; [et al.]
Model Predicting Survival/Exitus After Traumatic Brain Injury: Biomarker S100B 24H

2011- del Campo Pérez, Victor Miguel; Alvarez García, Elias; González Mao, Maria del Carmen; Andrade Olivie, María Amalia; Repáraz Andrade, Alfredo; [et al.]
Prognostic value of aberrant hypermethylation in pleural effusion of lung adenocarcinoma

2012- Botana Rial, María Isabel; Leiro Fernández, Virginia; Represas Represas, Cristina; del Campo Pérez, Victor Miguel; Fernández Villar, José Alberto [et al.]
Subgenomic RNA and Limited Cross-Reactive Neutralising Antibodies Point to Potential Improvements in SARS-CoV-2 Clinical Handling

2025- Daviña Núñez, Carlos; Pérez Castro, Sonia; Cabrera Alvargonzalez, Julio; González Alonso, Elena; Silva Bea, Sergio; [et al.]